Sichenzia Ross Friedman Ference LLP Represents Cynata on A$5.0M Private Placement
Press Release – New York – July 17, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that acted as US counsel to Australian-based stem cell and regenerative medicine provider Cynata Therapeutics Limited (ASX: CYP) in connection with a A$5 million private placement. The offering consisted of 6,670,000 shares of Cynata’s common stock and warrants priced at A$0.75 per share.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia and David Manno. H.C. Wainwright & Co. acted as the sole placement agent on the offering.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement - April 10, 2019
- Sichenzia Ross Ference LLP Congratulates INmune Bio Inc., on Initial Public Offering - April 10, 2019
- FDA sets first hearing on CBD in May as the agency looks at legalizing the cannabis compound in food and drinks - April 4, 2019